Medical Supply Stock Named 2021 Pick by J.P. Morgan

The firm raised its price target to $130 from $122

Assistant Editor
Dec 22, 2020 at 10:39 AM
facebook twitter linkedin


The shares of Medtronic PLC (NYSE:MDT) are up 0.3% at $114.74 at last check, after J.P. Morgan Securities made the stock a large-cap pick for 2021 and hiked its price target to $130 from $122. The firm cited the company's new CEO and operating model, and a strong product pipeline.

On the charts, MDT is still climbing steadily toward pre-pandemic levels, up around 59% since March. Today's earlier pullback to $114 was caught by the 10-day moving average. Year-to-date, the equity is just above its year-to-date breakeven mark. 

The majority of analysts are bullish on Medtronic stock, with 19 of the 21 in coverage at a "buy" or better rating. Furthermore, the 12-month consensus price target of $127.46 is an 11.4% premium to current levels. 

That said, now could be a good time to speculate on MDT's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 26% stands higher than just 13% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 

 

Grab Your FREE 5 Rules for Trading Stock Trends Report

1606854690

 




 
Special Offers from Schaeffer's Trading Partners